Search research articles
Contact Us
Filters
Showing results (81-90 of 145) with videos related to
Page
of 15
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
December 16, 2019
The Effect of Perimenopausal Transdermal Estradiol and Micronized Progesterone on Markers of Risk for Arterial Disease
Jennifer L Gordon, David R Rubinow, Lana Watkins, et al.
The American Journal of Psychiatry
|
April 3, 2013
Effects of pharmacologically induced hypogonadism on mood and behavior in healthy young women
Rivka Ben Dor, Veronica L Harsh, Paige Fortinsky, et al.
Psychosomatic Medicine
|
September 28, 2011
Psychiatric symptoms and proinflammatory cytokines in pregnancy
Emma Robertson Blackmore, Jan A Moynihan, David R Rubinow, et al.
The American Journal of Psychiatry
|
October 1, 2025
Differential Effects of Ovarian Steroids in Women With and Without Premenstrual Dysphoric Disorder: A Replication and Extension of Findings
Shau-Ming Wei, Paul Wakim, Pedro E Martinez, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 5, 2003
Differential menstrual cycle regulation of hypothalamic-pituitary-adrenal axis in women with premenstrual syndrome and controls
Catherine A Roca, Peter J Schmidt, Margaret Altemus, et al.
Brain Research. Molecular Brain Research
|
February 9, 2002
Dehydroepiandrosterone (DHEA) and its sulfated derivative (DHEAS) regulate apoptosis during neurogenesis by triggering the Akt signaling pathway in opposing ways
Lei Zhang, Bing shen Li, Wu Ma, et al.
Translational Psychiatry
|
March 7, 2019
Double-blind, randomized pilot clinical trial targeting alpha oscillations with transcranial alternating current stimulation (tACS) for the treatment of major depressive disorder (MDD)
Morgan L Alexander, Sankaraleengam Alagapan, Courtney E Lugo, et al.
Psychoneuroendocrinology
|
February 21, 2016
Histories of abuse predict stronger within-person covariation of ovarian steroids and mood symptoms in women with menstrually related mood disorder
Tory A Eisenlohr-Moul, David R Rubinow, Crystal E Schiller, et al.
JAMA
|
March 23, 2006
Shyness, social anxiety, and impaired self-esteem in Turner syndrome and premature ovarian failure
Peter J Schmidt, Graca M P Cardoso, Judith L Ross, et al.
The American Journal of Psychiatry
|
November 2, 2002
Effects of metergoline on symptoms in women with premenstrual dysphoric disorder
Catherine A Roca, Peter J Schmidt, Mark J Smith, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 145) with videos related to
Sort By:
Page
of 15
The Journal of Clinical Endocrinology and Metabolism
|
December 16, 2019
The Effect of Perimenopausal Transdermal Estradiol and Micronized Progesterone on Markers of Risk for Arterial Disease
Jennifer L Gordon, David R Rubinow, Lana Watkins, et al.
The American Journal of Psychiatry
|
April 3, 2013
Effects of pharmacologically induced hypogonadism on mood and behavior in healthy young women
Rivka Ben Dor, Veronica L Harsh, Paige Fortinsky, et al.
Psychosomatic Medicine
|
September 28, 2011
Psychiatric symptoms and proinflammatory cytokines in pregnancy
Emma Robertson Blackmore, Jan A Moynihan, David R Rubinow, et al.
The American Journal of Psychiatry
|
October 1, 2025
Differential Effects of Ovarian Steroids in Women With and Without Premenstrual Dysphoric Disorder: A Replication and Extension of Findings
Shau-Ming Wei, Paul Wakim, Pedro E Martinez, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 5, 2003
Differential menstrual cycle regulation of hypothalamic-pituitary-adrenal axis in women with premenstrual syndrome and controls
Catherine A Roca, Peter J Schmidt, Margaret Altemus, et al.
Brain Research. Molecular Brain Research
|
February 9, 2002
Dehydroepiandrosterone (DHEA) and its sulfated derivative (DHEAS) regulate apoptosis during neurogenesis by triggering the Akt signaling pathway in opposing ways
Lei Zhang, Bing shen Li, Wu Ma, et al.
Translational Psychiatry
|
March 7, 2019
Double-blind, randomized pilot clinical trial targeting alpha oscillations with transcranial alternating current stimulation (tACS) for the treatment of major depressive disorder (MDD)
Morgan L Alexander, Sankaraleengam Alagapan, Courtney E Lugo, et al.
Psychoneuroendocrinology
|
February 21, 2016
Histories of abuse predict stronger within-person covariation of ovarian steroids and mood symptoms in women with menstrually related mood disorder
Tory A Eisenlohr-Moul, David R Rubinow, Crystal E Schiller, et al.
JAMA
|
March 23, 2006
Shyness, social anxiety, and impaired self-esteem in Turner syndrome and premature ovarian failure
Peter J Schmidt, Graca M P Cardoso, Judith L Ross, et al.
The American Journal of Psychiatry
|
November 2, 2002
Effects of metergoline on symptoms in women with premenstrual dysphoric disorder
Catherine A Roca, Peter J Schmidt, Mark J Smith, et al.
Page
of 15